Mael Berre

Mael Berre serves as CEO, CTO at BforCure. BforCure operates in the research sector with approximately 28.0 employees. The company is headquartered in Paris, Ile-de-France. To date, BforCure has raised 2313170.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at BforCure.
• • 4,101 executive contacts are available in Ile-de-France.
• • Our database includes 201,468 c suite-level executives.

Gmail Google Apps Mapbox SendInBlue Google Tag Manager YouTube Mobile Friendly Squarespace ECommerce Remote AI

biotechnology research microbiota analysis single cell level molecular biology predictive analysis preventive analysis rapid diagnostics microbial mapping microorganism species fast testing biothreat detection antimicrobial resistance bioprotection chemical inputs reduction biohazards elimination pcr technology real-time analysis environmental monitoring food safety healthcare applications agricultural diagnostics multi-target detection high content pcr thermal rapid transition field deployable isolated microbial activity utility in winemaking perinatal health applications diagnostic accuracy molecular diffusion quantitative measurements patient safety contamination prevention emerging biothreats on-site testing sample collection accessibility affordable microbiology technological innovation scientific progress molecular petri dish polymers in diagnostics agile molecular biology user-friendly design real-world applications research & development laboratory integration testing software customer engagement data protection compliance privacy policy management

DG

David Gray CTO Hardware & Software at BforCure

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Mael Berre in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at BforCure.

Mael Berre's Position in the MessageCEO Database

• •Mael Berre is 1 of 2 verified executive contacts we track at BforCure.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •4,045 verified executive contacts in Ile-de-France are in the database.
• •42 verified contacts work at research companies in the 28.0 employee range (same size as BforCure).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Mael Berre directly?

Mael Berre's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO, CTO at BforCure. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Mael Berre work for?

Mael Berre is CEO, CTO at BforCure, a company in the research sector with 28.0 employees. The company is based in Paris, Ile-de-France.

Can I pitch or sell to Mael Berre?

As CEO, CTO at BforCure, Mael Berre is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Mael Berre directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Mael Berre in?

Mael Berre works in the research industry as CEO, CTO at BforCure. MessageCEO provides verified contact information for executives across all major industries.

Is Mael Berre's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mael Berre's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026